Viewing Study NCT06499350


Ignite Creation Date: 2025-12-24 @ 4:52 PM
Ignite Modification Date: 2026-01-02 @ 11:14 AM
Study NCT ID: NCT06499350
Status: RECRUITING
Last Update Posted: 2025-08-07
First Post: 2024-07-08
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study of FC084CSA in Combination of Tislelizumab in Patients With Advanced Malignant Solid Tumors
Sponsor: FindCure Biosciences (ZhongShan) Co., Ltd.
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2024-11-13
Start Date Type: ACTUAL
Primary Completion Date: 2026-02-01
Primary Completion Date Type: ESTIMATED
Completion Date: 2026-09-01
Completion Date Type: ESTIMATED
First Submit Date: 2024-07-08
First Submit QC Date: None
Study First Post Date: 2024-07-12
Study First Post Date Type: ACTUAL
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2025-08-06
Last Update Post Date: 2025-08-07
Last Update Post Date Type: ACTUAL